Anti-cyclic citrullinated peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Yin, Yufeng ^a   Liang, Di ^a   Zhao, Lidan ^a   Li, Yang ^a   Liu, Wei ^a   Ren, Yan ^a   Li, Yongzhe ^a   Zeng, Xiaofeng ^a   Zhang, Fengchun ^a   Tang, Fulin ^a   Shan, Guangliang ^b   Zhang, Xuan ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; PREDNISOLONE; RHEUMATOID FACTOR; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ADULT; ARTICLE; BLOOD SAMPLING; CHINA; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HOSPITAL SERVICE; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK FACTOR; BLOOD; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; IMMUNOLOGY; MULTIVARIATE ANALYSIS; RADIOGRAPHY;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDES, CYCLIC; RETROSPECTIVE STUDIES; RHEUMATOID FACTOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84899762727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092449     Document Type: Article

References (36)

1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324. PubMed: 3358796 (Pubitemid 18091653)
2. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2003) Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 62: 722-727. PubMed: 12860726 (Pubitemid 36886405)
3. Koduri G, Norton S, Young A, Cox N, Davies P, et al. (2010) Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford) 49: 1483-1489. PubMed: 20223814
4. Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, et al. (2011) Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med 183: 372-378. PubMed: 20851924
5. Turesson C, Matteson EL (2004) Management of extra-articular disease manifestations in rheumatoid arthritis. Curr Opin Rheumatol 16: 206-211. PubMed: 15103246 (Pubitemid 38530487)
6. Zeng X, Ai M, Tian X, Gan X, Shi Y, et al. (2003) Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis. J Rheumatol 30: 1451-1455. PubMed: 12858440 (Pubitemid 36835438)
7. Rodriguez-Mahou M, Lopez-Longo FJ, Sanchez-Ramon S, Estecha A, Garcia-Segovia A, et al. (2006) Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis. Arthritis Rheum 55: 657-661. PubMed: 16874789 (Pubitemid 44289887)
8. Rantapää-Dahlqvist S, de Jong BAW, Berglin E, Hallmans G, Wadell G, et al. (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis & Rheumatism 48: 2741-2749. PubMed: 14558078 (Pubitemid 37280601)
9. Reparon-Schuijt CC, van Esch WJ, van Kooten C, Schellekens GA, de Jong BA, et al. (2001) Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum 44: 41-47. PubMed: 11212174 (Pubitemid 32113116)
10. Lopez-Longo FJ, Oliver-Minarro D, de la Torre I, Gonzalez-Diaz de Rabago E, Sanchez-Ramon S, et al. (2009) Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum 61: 419-424. PubMed: 19333979
11. Liao KP, Gunnarsson M, Kallberg H, Ding B, Plenge RM, et al. (2009) Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis. Arthritis Rheum 60: 653-660. PubMed: 19248096
12. Alexiou I, Germenis A, Koutroumpas A, Kontogianni A, Theodoridou K, et al. (2008) Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol 27: 511-513. PubMed: 18172572
13. Gerli R, Bartoloni Bocci E, Sherer Y, Vaudo G, Moscatelli S, et al. (2008) Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis 67: 724-725. PubMed: 18408112 (Pubitemid 351571944)
14. Scott DL (2000) Prognostic factors in early rheumatoid arthritis. Rheumatology (Oxford) 39 Suppl 1: 24-29. PubMed: 11001376 (Pubitemid 30352940)
15. Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, et al. (2002) Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 29: 2074-2076. PubMed: 12375314
16. Inui N, Enomoto N, Suda T, Kageyama Y, Watanabe H, et al. (2008) Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis. Clin Biochem 41: 1074-1077. PubMed: 18638466
17. Jearn LH, Kim TY (2012) Level of anticitrullinated peptide/protein antibody is not associated with lung diseases in rheumatoid arthritis. J Rheumatol 39: 1493-1494. PubMed: 22753807
18. Aubart F, Crestani B, Nicaise-Roland P, Tubach F, Bollet C, et al. (2011) High levels of anti-cyclic citrullinated peptide autoantibodies are associated with cooccurrence of pulmonary diseases with rheumatoid arthritis. J Rheumatol 38: 979-982. PubMed: 21362759
19. American Thoracic Society, European Respiratory Society (2002) American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165: 277-304. PubMed: 11790668
20. van der Heijde DM, van 't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, et al. (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49: 916-920. PubMed: 2256738 (Pubitemid 20360757)
21. Zhang W, Shi Q, Zhao LD, Li Y, Tang FL, et al. (2010) The safety and effectiveness of a chloroform/methanol extract of Tripterygium wilfordii Hook F (T2) plus methotrexate in treating rheumatoid arthritis. J Clin Rheumatol 16: 375-378. PubMed: 21085018
22. Samouda H, Dutour A, Chaumoitre K, Panuel M, Dutour O, et al. (2013) VAT=TAAT-SAAT: innovative anthropometric model to predict visceral adipose tissue without resort to CT-Scan or DXA. Obesity (Silver Spring) 21: E41-50. PubMed: 23404678
23. Ellman P, Ball RE (1948) Rheumatoid disease with joint and pulmonary manifestations. Br Med J 2: 816-820. PubMed: 18890308
24. Brown KK (2007) Rheumatoid lung disease. Proc Am Thorac Soc 4: 443-448. PubMed: 17684286 (Pubitemid 47435369)
25. Castelino FV, Varga J (2010) Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther 12: 213. PubMed: 20735863
26. van Noord C, Hooijkaas H, Dufour-van den Goorbergh BC, van Hagen PM, van Daele PL, et al. (2005) Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjogren's syndrome. Ann Rheum Dis 64: 160-162. PubMed: 15608321 (Pubitemid 40075301)
27. Morita Y, Muro Y, Sugiura K, Tomita Y (2008) Anti-cyclic citrullinated peptide antibody in systemic sclerosis. Clin Exp Rheumatol 26: 542-547. PubMed: 18799082
28. Tobon GJ, Correa PA, Anaya JM (2005) Anti-cyclic citrullinated peptide antibodies in patients with primary Sjogren's syndrome. Ann Rheum Dis 64: 791-792. PubMed: 15834066 (Pubitemid 40559318)
29. Gottenberg JE, Mignot S, Nicaise-Rolland P, Cohen-Solal J, Aucouturier F, et al. (2005) Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome. Ann Rheum Dis 64: 114-117. PubMed: 15231509 (Pubitemid 40075286)
30. Saravanan V, Kelly CA (2004) Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis. Rheumatology (Oxford) 43: 143-147. PubMed: 12923285 (Pubitemid 38219666)
31. Ayhan-Ardic FF, Oken O, Yorgancioglu ZR, Ustun N, Gokharman FD (2006) Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms. Clin Rheumatol 25: 213-218. PubMed: 16091838 (Pubitemid 43372320)
32. Mori S, Koga Y, Sugimoto M (2012) Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir Med 106: 1591-1599. PubMed: 22867979
33. Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, et al. (2010) Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 62: 1583-1591. PubMed: 20155830
34. Zrour SH, Touzi M, Bejia I, Golli M, Rouatbi N, et al. (2005) Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis. Prospective study in 75 patients. Joint Bone Spine 72: 41-47. PubMed: 15681247 (Pubitemid 40169963)
35. Gochuico BR, Avila NA, Chow CK, Novero LJ, Wu HP, et al. (2008) Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 168: 159-166. PubMed: 18227362 (Pubitemid 351185882)
36. Brusselle G (2010) Rheumatoid arthritis and interstitial lung disease. Rheumatology (Oxford) 49: 1425-1426. PubMed: 20223815